跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 858 条关于
“dopa decarboxylase”
全部
858
临床试验
554
药物
204
机构
3
资讯
97
去年
FDA Approves PTC Therapeutics' KEBILIDI, First Gene Therapy Delivered Directly to the Brain for AADC Deficiency
去年
FDA Approves Kebilidi, First Brain-Delivered Gene Therapy for AADC Deficiency
去年
FDA Approves PTC Therapeutics' Gene Therapy KEBILIDI for AADC Deficiency
5个月前
New Cerebrospinal Fluid Biomarker Achieves 94-97% Accuracy in Diagnosing Parkinson's Disease and Lewy Body Dementia
3个月前
Merz Therapeutics Partners with Kvvit to Bring INBRIJA Parkinson's Treatment to Greater China
6个月前
Scientists Engineer Bacteria to Transform Plastic Waste into Parkinson's Drug L-DOPA
去年
FDA Approves First Gene Therapy for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
4年前
Intracerebroventricular Anaerobic Dopamine Reduces L-DOPA Complications in Parkinson's Disease
2个月前
Sinopia Biosciences' SB-0110 Shows Preclinical Promise in Boosting L-Dopa Efficacy While Reducing Dyskinesia in Parkinson's Disease
去年
FDA Approves PTC Therapeutics' Kebillidi, First Gene Therapy for AADC Deficiency
第 1 页,共 10 页
上一页
下一页